Oligonucleotides

Sumitomo Chemical has commissioned a new cGMP commercial-scale small molecules plant at its Oita site, adding new capacity to meet the growing demand of its global customer base, now offering more than 1,000m3 reactor capacity over 4 cGMP sites, guaranteeing security of supply for its new projects.   A brand-new state-of-the-art cGMP pilot plant will be opened in Osaka in fall for quick supply of the first GMP batches.